Overview

4.6 out of 5 (42 Reviews)

Credits

1.00

Post-Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

15 Feb 2025

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


Unlimited Nurse CE

Stay up to date on the latest medical knowledge with 6743 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 8017 hours of CE.

1 Year Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$39.99 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, was approved by the US Food and Drug Administration (FDA) to help improve glycemic control in adults with type 2 diabetes (T2D) when used alongside diet and exercise. Alogliptin enhances insulin secretion and reduces glucagon levels by prolonging incretin hormone activity. This drug selectively inhibits DPP-4 without affecting DPP-8 or DPP-9, thereby minimizing off-target toxicity. Alogliptin is available as an oral tablet and is administered once daily. Contraindications include hypersensitivity reactions such as anaphylaxis and angioedema. 

This activity reviews the indications, mechanism of action, contraindications, adverse event profile, administration, toxicity, and relevant drug interactions of alogliptin. This activity provides healthcare professionals with the knowledge and tools necessary for effectively managing T2D and related conditions with alogliptin, as well as for optimizing alogliptin therapy to deliver safe, targeted, and personalized care. This approach enables informed decision-making, allowing healthcare professionals to tailor treatment plans, optimize dosage regimens, and minimize adverse reactions, ultimately improving patient outcomes and advancing care standards. In addition, this activity emphasizes the importance of collaboration within the interprofessional healthcare team, clarifying roles to foster effective teamwork and optimizing patient outcomes.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify appropriate patient populations for alogliptin therapy and ensure it aligns with current clinical guidelines for managing type 2 diabetes.

  • Implement appropriate dosing regimens based on patient-specific factors, including renal function and coexisting conditions, to ensure optimal therapeutic outcomes.

  • Select appropriate complementary therapies and interventions, such as diet and exercise, to enhance the efficacy of alogliptin in managing type 2 diabetes.

  • Collaborate with other healthcare professionals, such as pharmacists and diabetes educators, to optimize alogliptin therapy and address any concerns or adverse events.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Nurses: StatPearls designates this activity for 1.00 ANCC contact hour(s). Nurses should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the US Food and Drug Administration. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Adam T. on 10/17/2021

Amy R. on 5/26/2022

Marti W. on 7/12/2022

Charles W. on 11/20/2022

Li Mei L. on 12/16/2022

YVELINE F. on 12/29/2022

Vinnie K. on 1/23/2023

Rose F. on 3/1/2023

Rebecca L. on 5/8/2023

Arelly J. on 5/17/2023

Elise F. on 6/24/2023

Stephanie D. on 6/17/2023

Daniel K. on 6/27/2023

Ryan H. on 9/17/2023

Shalamar S. on 11/12/2023

Sahar M. on 11/26/2023

Larry M. on 12/22/2023

Theresa C. on 1/9/2024

Genevieve M. on 1/29/2024

Hugo N. on 3/26/2024

None

Khodaidad B. on 3/27/2024

Anuradha S. on 4/28/2024

Mamta B. on 5/31/2024

Patricia C. on 6/2/2024

Madison C. on 6/2/2024

Lea S. on 6/11/2024

Hilina y. on 7/8/2024

Gautam P. on 9/30/2024

Mary Y. on 10/16/2024

Wendy S. on 10/16/2024

Dr Prashasti k. on 10/25/2024

Robert O. on 11/29/2024

Anish B. on 12/21/2024

Caroline S. on 1/4/2025

Fiorella Z. on 2/24/2025

Peter H. on 3/1/2025

A M. on 11/6/2023

Brenna B. on 10/29/2023

Maria L. on 9/27/2022

Nicole F. on 8/28/2022

Charity L. on 4/12/2022

Jacqueline M. on 2/8/2025

Unlimited Nurse CE

Stay up to date on the latest medical knowledge with 6743 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 8017 hours of CE.

1 Year Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$39.99 per 1 year per user